全文获取类型
收费全文 | 3318104篇 |
免费 | 257130篇 |
国内免费 | 6473篇 |
专业分类
耳鼻咽喉 | 49883篇 |
儿科学 | 103593篇 |
妇产科学 | 91613篇 |
基础医学 | 463640篇 |
口腔科学 | 99154篇 |
临床医学 | 296240篇 |
内科学 | 641379篇 |
皮肤病学 | 71547篇 |
神经病学 | 275724篇 |
特种医学 | 133616篇 |
外国民族医学 | 1263篇 |
外科学 | 508243篇 |
综合类 | 78849篇 |
现状与发展 | 7篇 |
一般理论 | 1325篇 |
预防医学 | 255299篇 |
眼科学 | 80925篇 |
药学 | 249696篇 |
6篇 | |
中国医学 | 6469篇 |
肿瘤学 | 173236篇 |
出版年
2018年 | 33488篇 |
2016年 | 29260篇 |
2015年 | 32990篇 |
2014年 | 46512篇 |
2013年 | 70773篇 |
2012年 | 95107篇 |
2011年 | 99894篇 |
2010年 | 58929篇 |
2009年 | 56372篇 |
2008年 | 95446篇 |
2007年 | 102430篇 |
2006年 | 103329篇 |
2005年 | 101334篇 |
2004年 | 97483篇 |
2003年 | 94420篇 |
2002年 | 93104篇 |
2001年 | 151914篇 |
2000年 | 156797篇 |
1999年 | 132506篇 |
1998年 | 35867篇 |
1997年 | 32299篇 |
1996年 | 31446篇 |
1995年 | 32219篇 |
1994年 | 30212篇 |
1993年 | 28080篇 |
1992年 | 105665篇 |
1991年 | 102075篇 |
1990年 | 99090篇 |
1989年 | 95841篇 |
1988年 | 88992篇 |
1987年 | 87737篇 |
1986年 | 83528篇 |
1985年 | 79836篇 |
1984年 | 60280篇 |
1983年 | 51251篇 |
1982年 | 31149篇 |
1981年 | 27882篇 |
1979年 | 57224篇 |
1978年 | 40469篇 |
1977年 | 34550篇 |
1976年 | 31951篇 |
1975年 | 34800篇 |
1974年 | 42271篇 |
1973年 | 40527篇 |
1972年 | 38419篇 |
1971年 | 35788篇 |
1970年 | 33783篇 |
1969年 | 31665篇 |
1968年 | 29218篇 |
1967年 | 26217篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
Anand Rajan Peerapol Wangrattanapranee Jonathan Kessler Trilokesh Dey Kidambi James H Tabibian 《World journal of gastrointestinal surgery》2022,14(4):286-303
Gastrostomy tube placement is a procedure that achieves enteral access for nutrition, decompression, and medication administration. Preprocedural evaluation and selection of patients is necessary to provide optimal benefit and reduce the risk of adverse events (AEs). Appropriate indications, contraindications, ethical considerations, and comorbidities of patients referred for gastrostomy placement should be weighed and balanced. Additionally, endoscopist should consider either a transoral or transabdominal approach is appropriate, and radiologic or surgical gastrostomy tube placement is needed. However, medical history, physical examination, and imaging prior to the procedure should be considered to tailor the appropriate approach and reduce the risk of AEs. 相似文献
42.
Cornelius Anna Pilger Daniel Riechardt Aline Reitemeyer Emanuel Rübsam Anne Winterhalter Sibylle Maier Anna-Karina B. 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2022,260(3):957-965
Graefe's Archive for Clinical and Experimental Ophthalmology - To compare the blood flow situation in primary open-angle glaucoma (POAG) and pseudoexfoliation glaucoma (PXG) using optical... 相似文献
43.
44.
45.
Stephanie H. Ameis John D. Haltigan Rachael E. Lyon Amanda Sawyer Pat Mirenda Connor M. Kerns Isabel M. Smith Tracy Vaillancourt Joanne Volden Charlotte Waddell Lonnie Zwaigenbaum Teresa Bennett Eric Duku Mayada Elsabbagh Stelios Georgiades Wendy J. Ungar Anat Zaidman-Zait Meng-Chuan Lai Peter Szatmari for the Pathways in ASD Study Team 《Journal of child psychology and psychiatry, and allied disciplines》2022,63(5):553-562
46.
47.
48.
Pontevedra Paula Lopez-Suarez Carlos Rodriguez Veronica Pelaez Jesus Suarez Maria J. 《Clinical oral investigations》2022,26(6):4327-4335
Clinical Oral Investigations - To evaluate and to compare the clinical performance and survival rate of posterior monolithic and veneered zirconia fixed partial dentures (FPDs). Sixty 3-unit... 相似文献
49.
Hendrik Kröning Thomas Göhler Thomas Decker Marc Grundeis Georgi Kojouharoff Jörg Lipke Dieter Semsek Enno Moorahrend Annette Sauer Harald-Robert Bruch Rüdiger Liersch Arnd Nusch Ursula Vehling-Kaiser Manfred Welslau Ralf Grunewald Hanns-Detlev Harich Marcel Stephany Jens Uhlig Rebecca de Buhr Melanie Frank Cathrin Hogrefe Norbert Marschner Karin Potthoff Frank Hartmann Timo Reisländer Ingo Schwaner 《International journal of cancer. Journal international du cancer》2023,153(6):1227-1240
The prospective, multicenter, noninterventional TACTIC study assessed effectiveness and safety of trifluridine/tipiracil (FTD/TPI) in patients with metastatic colorectal cancer (mCRC) in a real-world setting in Germany, thus evaluating the external validity of the findings from the pivotal RECOURSE trial. Primary endpoint was overall survival (OS). Secondary objectives included progression-free survival (PFS), safety, and quality of life (QoL). Subgroups comprised patients with good (<3 metastatic sites at inclusion, ≥18 months from diagnosis of first metastasis to inclusion) or poor (remaining patients) prognostic characteristics (GPC/PPC). GPC without liver metastases was considered best prognostic characteristics (BPC). In total, 307 eligible patients (pretreated or not suitable for other available therapies) were treated with FTD/TPI. Overall, median [95%-CI] OS was 7.4 months [6.4-8.6], median PFS was 2.9 months [2.8-3.3]. In BPC (n = 65) and GPC (n = 176) compared to PPC (n = 124) subgroup, median OS (13.3 [9.1-17.6] vs 8.9 [7.6-9.8] vs 5.1 [4.4-7.0] months) and median PFS (4.0 [3.3-5.3] vs 3.4 [3.0-3.7] vs 2.6 [2.4-2.8] months) were longer. Patient-reported QoL, assessed by validated questionnaires (EQ-5D-5L, PRO-CTCAE), was stable throughout FTD/TPI treatment. Predominant FTD/TPI-related adverse events of grades 3 or 4 were neutropenia (13.0%), leukopenia (7.5%), and anemia (5.2%). Altogether, palliative FTD/TPI therapy in patients with pretreated mCRC was associated with prolonged survival, delayed progression, maintained health-related QoL, and manageable toxicity. Low metastatic burden and indolent disease were favorable prognostic factors for survival. TACTIC confirms the effectiveness and safety of FTD/TPI, highlighting its value in routine clinical practice. 相似文献
50.
Sara Järpestam Louise Martinell Christian Rylander Linus Lilja 《Acta anaesthesiologica Scandinavica》2023,67(9):1249-1255